✦ LIBER ✦

Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC)

✍ Scribed by Susana Cedrés Pérez; Isela Quispe; Pablo Martínez; Marina Longo; Eva Rodríguez; César Serrano; Eva Muñoz; Esther Pallisa; Enriqueta Felip

Book ID: 107597742
Publisher: Springer Milan
Year: 2010
Tongue: Spanish
Weight: 335 KB
Volume: 12
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-010-0605-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

109P COMPUTED TOMOGRAPHY (CT) PREDICTS A

109P COMPUTED TOMOGRAPHY (CT) PREDICTS ACCURATELY THE PATHOLOGIC TUMOR SIZE IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC)

✍ Pérez, S.M. Cedrés; Quispe, I.; Serrano, C.; Martínez, P.; Bra≁a, I.; Rodríguez, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Prognostic Value of Computed Tomography

Prognostic Value of Computed Tomography Morphologic Characteristics in Stage I Non–Small-Cell Lung Cancer

✍ Inja Neralic Meniga; Mirjana Kujundzic Tiljak; Davor Ivankovic; Ivan Aleric; Mir 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 842 KB

POINT: Clinical stage IA non–small cell

POINT: Clinical stage IA non–small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non–small cell lung cancer: The problem of understaging

✍ Brendon M. Stiles; Elliot L. Servais; Paul C. Lee; Jeffrey L. Port; Subroto Paul 📂 Article 📅 2009 🏛 CTSNet 🌐 English ⚖ 156 KB

Adjuvant treatment in resected stage II

Adjuvant treatment in resected stage II & III non-small cell lung cancer (NSCLC) patients (PTS) with preoperative false-negative chest computed tomography (CT) scans

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 129 KB

CT of brain and clinical evaluation in t

CT of brain and clinical evaluation in the initial staging of non-small cell lung cancer (NSCLC)

✍ Yilmaz, MU; Ediboǧlu, H; Yasan, H; Kara, S; Yüksel, M 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Ribonucleotide reductase subunit 2 (RRM2

Ribonucleotide reductase subunit 2 (RRM2) predicts shorter survival in resected stage I–III non-small cell lung cancer (NSCLC) patients

✍ Grossi, F.; Rijavec, E.; Dal Bello, M.G.; Savarino, G.; Sini, C.; Barletta, G.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB